These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7276209)

  • 21. LABORATORY STUDIES ON PATIENTS RECEIVING ANTICOAGULANT THERAPY.
    SHAW S; PEGRUM GD; WOLFF S
    J Clin Pathol; 1965 May; 18(3):327-9. PubMed ID: 14304246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aluminum content of source plasma and sodium citrate anticoagulant.
    May JC; Rains TC; Yu LJ; Etz NM
    Vox Sang; 1992; 62(2):65-9. PubMed ID: 1519369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. THE LABORATORY CONTROL OF ANTICOAGULANT THERAPY. QUICK'S ONE-STAGE PROTHROMBIN TIME COMPARED WITH THROMBOTEST.
    COUNIHAN TB; FARRELL I; KEELAN P
    Ir J Med Sci; 1964 Jan; 457():31-6. PubMed ID: 14113901
    [No Abstract]   [Full Text] [Related]  

  • 24. An assessment of an amidolytic assay for factor VII in the laboratory control of oral anticoagulants.
    Poller L; Thomson JM; Bodzenta A; Easton AC; Latallo ZS; Chmielewska J
    Br J Haematol; 1981 Sep; 49(1):69-75. PubMed ID: 7272230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prothrombin time test: effect of varying citrate concentration.
    Ingram GI; Hills M
    Thromb Haemost; 1976 Aug; 36(1):230-6. PubMed ID: 1036813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PROTHROMBIN-TIME AND THROMBOTEST IN INJURED PATIENTS ON PROPHYLACTIC ANTICOAGULANT THERAPY.
    SEVITT S; INNES D
    Lancet; 1964 Jan; 1(7325):124-9. PubMed ID: 14074476
    [No Abstract]   [Full Text] [Related]  

  • 27. Implications of anticoagulants and gender on cell counts and growth factor concentration in platelet-rich plasma and platelet-rich gel supernatants from rabbits.
    González JC; López C; Carmona JU
    Vet Comp Orthop Traumatol; 2016; 29(2):115-24. PubMed ID: 26786984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of sodium bicarbonate on in vitro conversion of fibrinogen to fibrin.
    Wong DW
    J Pharm Sci; 1980 Aug; 69(8):978-80. PubMed ID: 7400952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. OBSERVATIONS ON THE USE OF THE BECTON DICKINSON FIBROMETER.
    WYLIE CR; FRASER C
    J Clin Pathol; 1965 May; 18(3):372-4. PubMed ID: 14304257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Citrate regional anticoagulation in haemodialysis.
    Hocken AG; Hurst PL
    Nephron; 1987; 46(1):7-10. PubMed ID: 3600914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CONTROL OF ANTICOAGULANT THERAPY BY THROMBOTEST METHOD.
    KEYSER JW
    Br Med J; 1963 Dec; 2(5371):1514-6. PubMed ID: 14063080
    [No Abstract]   [Full Text] [Related]  

  • 32. AN ASSESSMENT OF ANTICOAGULANT THERAPY AND COMPARISON OF QUICK TEST, THROMBOTEST AND 2.7.10 REAGENTS.
    TAYLOR DM; STENBECK CL; ERENSTROM AJ
    N Z Med J; 1965 Jan; 64():29-34. PubMed ID: 14257136
    [No Abstract]   [Full Text] [Related]  

  • 33. Optimal volume of anticoagulant citrate dextrose solution in the preparation of technetium Tc 99m-labeled red blood cells.
    Hung JC; Wilson ME
    Am J Hosp Pharm; 1994 Nov; 51(21):2699-701. PubMed ID: 7856584
    [No Abstract]   [Full Text] [Related]  

  • 34. [TRIALS ON THE CAPILLARY BLOOD METHOD FOR THE CONTROL OF ANTICOAGULANT THERAPY: THE OWREN THROMBOTEST AND HARTERT PROTHROMBIN TIME].
    FISCHER M
    Thromb Diath Haemorrh; 1964 Apr; 11():243-53. PubMed ID: 14167109
    [No Abstract]   [Full Text] [Related]  

  • 35. Agreement of Owren and Quick prothrombin times: effects of citrate and calcium concentrations and international sensitivity index correction.
    Horsti J
    Clin Chem; 2001 May; 47(5):940-4. PubMed ID: 11325902
    [No Abstract]   [Full Text] [Related]  

  • 36. [The Quick test and Owren's thrombotest in the control of anticoagulant therapy in ophthalmology].
    LEPRI G; PARDUCCI F
    Ann Ottalmol Clin Ocul; 1962 Apr; 88():117-24. PubMed ID: 13929809
    [No Abstract]   [Full Text] [Related]  

  • 37. Use of chromogenic peptide substrates in the determination of clotting factors II, VII, IX and X in normal plasma and in plasma of patients treated with oral anticoagulants.
    van Dieijen-Visser MP; van Wersch J; Brombacher PJ; Rosing J; Hemker HC; van Dieijen G
    Haemostasis; 1982; 12(3):241-55. PubMed ID: 7141303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Citrate haemodialysis.
    Faber LM; de Vries PM; Oe PL; van der Meulen J; Donker AJ
    Neth J Med; 1990 Dec; 37(5-6):219-24. PubMed ID: 2074914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thrombotest-a new method for the control of oral anticoagulant medication.
    VETNE G
    J Mich State Med Soc; 1961 Dec; 60():1533-6. PubMed ID: 13925672
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of sodium citrate, citric acid and lactic acid on human blood coagulation.
    Scaravilli V; Di Girolamo L; Scotti E; Busana M; Biancolilli O; Leonardi P; Carlin A; Lonati C; Panigada M; Pesenti A; Zanella A
    Perfusion; 2018 Oct; 33(7):577-583. PubMed ID: 29783879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.